Ann: Successful Completion of In Vitro Studies, page-5

Thank you for this hilarious interpretation of the share price action, by which you've been able to protect yourself from having to re-evaluate your investment decision. Well done, you've made my Christmas!

I suspect the market is disappointed because:

1. Many of the claims of neuroprotective and neuroregenerative properties mentioned in the earlier results have disappeared from this release.
2. Showing results "better than CBD alone" is meaningless because CBD isn't indicated in these contexts anyway. It's like saying "panadol is better for reducing pain than a measles vaccination".

Brian Leedman's arrival and marketing activities created positive expectations, which these results don't meet.

At least the chemicals are active, so there's still value in continuing to look for conditions that it can treat. If there is such a condition they haven't found it yet